Adela Dzwonkowska

Adela Dzwonkowska

Auto-generated profile, based on publicly available information

Adela Dzwonkowska

Szpitale Tczewskie S.A., Tczew, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ADAdela Dzwonkowska
Adela Dzwonkowska
JDJakub Dzwonkowski
Jakub Dzwonkowski
AKAlicja Kozłowska
Alicja Kozłowska
KPKarolina Przybysz
Karolina Przybysz
JRJarosław Rachoń
Jarosław Rachoń
NZNatalia Zienkiewicz
Natalia Zienkiewicz
Background: Artificial intelligence (AI) has become a promising tool in dermatology that could improve diagnostic accuracy, optimize clinical workflows, and expand access to dermatological care. Recent advances in machine learning and deep learning have enabled the development of highly accurate image-analysis systems, particularly for the diagnosis of skin lesions. However, the implementation of AI in clinical practice is accompanied by important ethical, legal, and equity-related challenges. Objective: This narrative review aims to summarize the current evidence regarding the applications of artificial intelligence in dermatology, with particular emphasis on its potential to improve healthcare accessibility, support teledermatology, and promote health equity while addressing existing limitations and ethical concerns. Methods: A narrative review of the literature was conducted using PubMed, PubMed Central, and Google Scholar. Peer-reviewed articles published in English between 2017 and 2025 were included. The literature was selected using keywords related to artificial intelligence, dermatology, skin cancer, teledermatology, and health equity. Results: The reviewed literature demonstrates that AI has achieved high diagnostic performance in the recognition of various skin diseases, particularly malignant skin lesions, and may significantly improve access to dermatological services through teledermatology and decision-support systems. Nevertheless, challenges including algorithmic bias, limited representation of diverse skin phototypes in training datasets, data privacy concerns, and insufficient regulatory frameworks remain substantial barriers to widespread implementation. Conclusions: Artificial intelligence has the potential to transform dermatological care by enhancing diagnostic efficiency and improving healthcare accessibility. However, its successful integration into clinical practice requires diverse and representative datasets, robust ethical and legal standards, and continued human oversight to ensure safe, equitable, and patient-centered healthcare.

2 July 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ADAdela Dzwonkowska
Adela Dzwonkowska
JDJakub Dzwonkowski
Jakub Dzwonkowski
AKAlicja Kozłowska
Alicja Kozłowska
KPKarolina Przybysz
Karolina Przybysz
JRJarosław Rachoń
Jarosław Rachoń
NZNatalia Zienkiewicz
Natalia Zienkiewicz
Air pollution is recognized as one of the leading environmental determinants of human health. It has been associated with a growing burden of respiratory diseases worldwide. Allergic rhinitis (AR), a chronic inflammatory disorder of the upper airways, may be susceptible to the effects of environmental pollutants. This narrative review aimed to summarize current evidence regarding the impact of air pollution on allergic rhinitis severity, disease control, and quality of life in adults. A literature search was conducted using the PubMed database. Relevant publications were identified using combinations of the keywords with priority given to recent systematic reviews, meta-analyses, observational studies, clinical investigations, and international clinical guidelines. The reviewed evidence consistently demonstrated positive associations between exposure to ambient air pollutants and allergic rhinitis outcomes. Particulate matter (PM2.5 and PM10), nitrogen dioxide (NO₂), ozone (O₃), and sulfur dioxide (SO₂) were most frequently associated with increased symptom severity, poorer disease control, and reduced quality of life. Particulate matter showed the strongest and most consistent relationship with allergic rhinitis burden. Proposed biological mechanisms include oxidative stress, epithelial barrier dysfunction, chronic inflammation, and immune dysregulation. In conclusion, air pollution represents an important and potentially modifiable determinant of allergic rhinitis severity and quality of life. Improving air quality and reducing individual exposure to environmental pollutants may contribute to better disease control and reduced burden of allergic respiratory diseases, highlighting the importance of both clinical and public health interventions.

2 July 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
DTDaria Trocka
Daria Trocka
NWNatalia Woroniecka
Natalia Woroniecka
NSNicol Szerenos
Nicol Szerenos
AKAlicja Kozłowska
Alicja Kozłowska
KPKarolina Przybysz
Karolina Przybysz
JDJakub Dzwonkowski
Jakub Dzwonkowski
Obesity has been increasingly recognized as a potential modifiable risk factor for cognitive dysfunction and dementia. Accumulating evidence indicates that excess adiposity is associated with impairments in multiple cognitive domains, particularly executive function, attention, processing speed, and, to a lesser extent, memory. The strongest and most consistent associations are observed in midlife obesity, suggesting a life-course effect of prolonged metabolic exposure on brain health. This narrative review synthesizes current epidemiological, neuroimaging, mechanistic, and interventional evidence linking obesity with cognitive outcomes. Structural and functional brain alterations associated with obesity include reduced gray matter volume, white matter integrity disruption, and altered connectivity within key cognitive networks such as frontoparietal and hippocampal circuits. Proposed biological mechanisms include chronic low-grade systemic inflammation, insulin resistance with impaired central glucose metabolism, cerebrovascular dysfunction, oxidative stress, adipokine imbalance, and gut–brain axis alterations. The relationship between obesity and cognition is further modified by age, adiposity distribution, metabolic health status, genetic susceptibility, and lifestyle factors, indicating substantial inter-individual heterogeneity. Emerging interventional evidence suggests that cognitive impairment associated with obesity may be at least partially reversible, particularly following lifestyle modification, multidomain interventions, bariatric surgery, and pharmacological treatments targeting metabolic pathways; however, long-term randomized controlled data remain limited. Overall, obesity should be considered a heterogeneous and potentially modifiable risk factor for cognitive decline, with early metabolic intervention representing a promising strategy for preserving long-term cognitive health.

2 July 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
NSNicol Szerenos
Nicol Szerenos
NWNatalia Woroniecka
Natalia Woroniecka
DTDaria Trocka
Daria Trocka
AKAlicja Kozłowska
Alicja Kozłowska
KPKarolina Przybysz
Karolina Przybysz
JDJakub Dzwonkowski
Jakub Dzwonkowski
Cardiovascular disease remains the leading cause of morbidity and mortality among patients with type 2 diabetes mellitus (T2DM). In recent years, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as an important therapeutic class capable of providing cardiovascular benefits beyond glycemic control. This review aimed to evaluate the current evidence regarding the cardiovascular effects of GLP-1RAs, with particular emphasis on findings from major cardiovascular outcome trials (CVOTs). A narrative review of randomized controlled trials, meta-analyses, and contemporary clinical guidelines was conducted. Major CVOTs evaluating lixisenatide, liraglutide, semaglutide, exenatide, albiglutide, dulaglutide, oral semaglutide, and efpeglenatide were analyzed with respect to major adverse cardiovascular events (MACE), cardiovascular mortality, stroke, myocardial infarction, heart failure, and renal outcomes. The available evidence demonstrates that several GLP-1RAs significantly reduce cardiovascular risk in patients with T2DM. Liraglutide, semaglutide, dulaglutide, albiglutide, and efpeglenatide consistently showed reductions in MACE, while meta-analyses confirmed favorable effects on cardiovascular mortality, all-cause mortality, and stroke. Additional benefits included improved renal outcomes and clinically meaningful weight loss. Recent evidence from the SELECT trial further suggests that cardiovascular protection may extend to individuals with overweight or obesity without diabetes. In conclusion, GLP-1 receptor agonists have evolved from glucose-lowering agents into therapies with established cardioprotective properties. Their ability to improve cardiovascular outcomes and reduce cardiometabolic risk supports their central role in contemporary diabetes management and cardiovascular prevention strategies.

2 July 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
KPKarolina Przybysz
Karolina Przybysz
LSLuiza Stadnik
Luiza Stadnik
AKAlicja Kozłowska
Alicja Kozłowska
NSNicol Szerenos
Nicol Szerenos
ADAdela Dzwonkowska
Adela Dzwonkowska
NWNatalia Woroniecka
Natalia Woroniecka
Background: Gastrointestinal (GI) symptoms are common among endurance athletes and may impair performance, particularly during prolonged, high-intensity exercise in hot environments or under conditions of dehydration. These disturbances are collectively referred to as Exercise-Induced Gastrointestinal Syndrome (EIGS). Objective: This review summarizes current evidence on the epidemiology, pathophysiological mechanisms, consequences, and prevention strategies for EIGS in endurance athletes. Methods: A narrative review of the literature was conducted, focusing on the prevalence of GI symptoms during endurance exercise, the underlying mechanisms of EIGS—including splanchnic hypoperfusion, epithelial barrier disruption, ischemia-reperfusion injury, mechanical stress, nutritional factors, and neuroendocrine responses—and evidence-based prevention and management strategies. Results: GI symptoms affect approximately 30–50% of endurance athletes, with the highest prevalence reported in marathon, ultra-endurance, and triathlon events. EIGS results from the interaction of reduced splanchnic blood flow, hyperthermia, epithelial injury, and nutritional and mechanical stress, leading to increased intestinal permeability, inflammation, impaired fluid and nutrient absorption, dehydration, and reduced athletic performance. Hypertonic carbohydrate intake, high-FODMAP foods, and nonsteroidal anti-inflammatory drug use may increase symptom risk. Individualized nutrition and hydration strategies, gut training, and low-FODMAP dietary approaches in susceptible athletes may reduce symptom severity. Conclusions: EIGS is a multifactorial condition driven by interacting circulatory, thermal, mechanical, nutritional, and neuroendocrine stressors. Although no single intervention completely prevents GI symptoms, individualized fueling strategies and gut training appear to be the most effective current approaches. Further research is needed to optimize prevention and identify factors underlying individual susceptibility.

3 August 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
LSLuiza Stadnik
Luiza Stadnik
AKAlicja Kozłowska
Alicja Kozłowska
KPKarolina Przybysz
Karolina Przybysz
NWNatalia Woroniecka
Natalia Woroniecka
ADAdela Dzwonkowska
Adela Dzwonkowska
JDJakub Dzwonkowski
Jakub Dzwonkowski
Background. Blood cortisol is a key biomarker of hypothalamic-pituitary-adrenal (HPA) axis activity and is widely used in sports science to assess physiological and psychological stress.However, its interpretation is limited by considerable biological variability and multiple influencing factors. Aim. To summarize current evidence on the physiological role of blood cortisol in endurance exercise and its usefulness for monitoring training load, recovery, and adaptation. Material and methods. A narrative review of peer-reviewed studies, systematic reviews,meta-analyses, and guidelines on cortisol physiology, exercise endocrinology, and athlete monitoring was conducted. Results. Blood cortisol reflects the physiological stress response and supports metabolic andimmune regulation during endurance exercise. Acute increases are a normal adaptive response, whereas persistent alterations may indicate excessive training stress when interpreted in context. Due to circadian variation and other confounding factors, single measurements have limited value. Current evidence favors longitudinal within-athlete monitoring combined with physiological, psychometric, hormonal, and performance measures.Conclusions. Blood cortisol is a useful component of endurance athlete monitoring butshould not be used as a stand-alone marker. Its greatest value lies in repeated standardized assessments interpreted within a multimodal monitoring approach. Key words: cortisol, endurance training, exercise physiology, training monitoring, trainingload, physiological stress, overtraining syndrome, athlete monitoring, Hypothalamic-Pituitary-Adrenal Axis